UB Paderborn / Katalog / Suche / in CDI

Cholesteryl ester transfer protein inhibitors: challenges and perspectives

Expert review of cardiovascular therapy, 2016-08, Vol.14 (8), p.953-962

2016

Volltextzugriff (PDF)

Statin escape phenomenon: Does it really exist? Evidence from a lipid clinic

Atherosclerosis, 2016-09, Vol.252, p.e55-e55

2016

Volltextzugriff (PDF)

CHADS2 and CHA2DS2-Vasc scores predict cardiovascular disease in statin-treated individuals without atrial fibrillation

Atherosclerosis, 2016-09, Vol.252, p.e10-e10

2016

Volltextzugriff (PDF)

Risk of incident diabetes among patients treated with statins ± ezetimibe: Lessons from a lipid clinic after an 8-year follow-up

Atherosclerosis, 2015-07, Vol.241 (1), p.e223-e224

2015

Volltextzugriff (PDF)

Incidence of cardiovascular disease among individuals with and without familial hypercholesterolemia attending a lipid clinic

Atherosclerosis, 2016-09, Vol.252, p.e45-e45

2016

Volltextzugriff (PDF)

Lipid-lowering therapy and target attainment among hypelipidemic individuals with or without familial hypercholesterolemia: Evidence from a lipid clinic

Atherosclerosis, 2016-09, Vol.252, p.e44-e45

2016

Volltextzugriff (PDF)

Switch to rosuvastatin versus addition of ezetimibe in patients receiving atorvastatin: Effect on urine 8-isoprostane levels

Atherosclerosis, 2016-09, Vol.252, p.e29-e29

2016

Volltextzugriff (PDF)

Proton pump inhibitors and statins: a combination that favors ldl-c reduction?

Atherosclerosis, 2015-07, Vol.241 (1), p.e202-e202

2015

Volltextzugriff (PDF)

Attainment of multifactorial treatment targets among elderly in a lipid clinic

Atherosclerosis, 2015-07, Vol.241 (1), p.e200-e200

2015

Volltextzugriff (PDF)

Effect of valsartan/hydrochlorothiazide combination on low-density-lipoprotein particle size and plasma lipoprotein-associated phospholipase A2 activity in hypertensive patients with metabolic syndrome

Atherosclerosis, 2014-08, Vol.235 (2), p.e264-e264

2014

Volltextzugriff (PDF)

Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?

Hippokratia, 2015-01, Vol.19 (4), p.332-337

2015

Volltextzugriff (PDF)

The effects of pioglitazone treatment in lipidemic profile and elastographic indices in non-diabetic patients with nash

Atherosclerosis, 2020-12, Vol.315, p.e263-e263

2020

Volltextzugriff (PDF)

Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece

Atherosclerosis, 2022-08, Vol.355, p.186-186

2022

Volltextzugriff (PDF)

Modifiable and non-modifiable cardiovascular risk factors on sensory disorder of smell and taste in COVID-19 population

Atherosclerosis, 2022-08, Vol.355, p.186-187

2022

Volltextzugriff (PDF)

Hyponatremia Is Associated With Increased The Mortality In Patients With Acute Stroke: A Systematic Review And Meta-Analysis

Atherosclerosis, 2019-08, Vol.287, p.e87-e87

2019

Volltextzugriff (PDF)

Glucagon-Like Peptide 1 Receptor Agonists Protect Against Stroke In Patients With Diabetes: A Systematic Review And Meta-Analysis

Atherosclerosis, 2019-08, Vol.287, p.e116-e116

2019

Volltextzugriff (PDF)

Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Atherosclerosis, 2022-08, Vol.355, p.122

2022

Volltextzugriff (PDF)

Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Atherosclerosis, 2022-08, Vol.355, p.125-126

2022

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and its association with incident diabetes in statin-treated individuals

Atherosclerosis, 2018-08, Vol.275, p.e196-e196

2018

Volltextzugriff (PDF)

Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Atherosclerosis, 2022-08, Vol.355, p.122-123

2022

Volltextzugriff (PDF)

Inhibition of hydroxyapatite formation in the presence of titanocene–aminoacid complexes: an experimental and computational study

Journal of materials science. Materials in medicine, 2015-01, Vol.26 (1), p.1-13, Article 15

2015

Volltextzugriff (PDF)

Inhibition of hydroxyapatite formation in the presence of titanocene-amino acid complexes: an experimental and computational study

Journal of materials science. Materials in medicine, 2015-01, Vol.26 (1), p.5341-5341

2015

Volltextzugriff (PDF)

Inhibition of Hydroxyapatite Crystal Growth by Substituted Titanocenes

Langmuir, 2000-08, Vol.16 (16), p.6745-6749

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Cholesteryl ester transfer protein inhibitors: challenges and perspectives

Statin escape phenomenon: Does it really exist? Evidence from a lipid clinic

CHADS2 and CHA2DS2-Vasc scores predict cardiovascular disease in statin-treated individuals without atrial fibrillation

Risk of incident diabetes among patients treated with statins ± ezetimibe: Lessons from a lipid clinic after an 8-year follow-up

Incidence of cardiovascular disease among individuals with and without familial hypercholesterolemia attending a lipid clinic

Lipid-lowering therapy and target attainment among hypelipidemic individuals with or without familial hypercholesterolemia: Evidence from a lipid clinic

Switch to rosuvastatin versus addition of ezetimibe in patients receiving atorvastatin: Effect on urine 8-isoprostane levels

Proton pump inhibitors and statins: a combination that favors ldl-c reduction?

Attainment of multifactorial treatment targets among elderly in a lipid clinic

Effect of valsartan/hydrochlorothiazide combination on low-density-lipoprotein particle size and plasma lipoprotein-associated phospholipase A2 activity in hypertensive patients with metabolic syndrome

Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?

The effects of pioglitazone treatment in lipidemic profile and elastographic indices in non-diabetic patients with nash

Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece

Modifiable and non-modifiable cardiovascular risk factors on sensory disorder of smell and taste in COVID-19 population

Hyponatremia Is Associated With Increased The Mortality In Patients With Acute Stroke: A Systematic Review And Meta-Analysis

Glucagon-Like Peptide 1 Receptor Agonists Protect Against Stroke In Patients With Diabetes: A Systematic Review And Meta-Analysis

Comparative effect of delapril-manidipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Comparative effect of valsartan-amlodipine treatment versus telmisartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Non-alcoholic fatty liver disease and its association with incident diabetes in statin-treated individuals

Thrombotic and thromboembolic events in COVID-19 patients: Association with clinical presentation, progression and laboratory findings. Data analysis of a 681 patient cohort

Comparative effect of delapril-manidipine treatment versus valsartan-amlodipine treatment in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients

Inhibition of hydroxyapatite formation in the presence of titanocene–aminoacid complexes: an experimental and computational study

Inhibition of hydroxyapatite formation in the presence of titanocene-amino acid complexes: an experimental and computational study

Inhibition of Hydroxyapatite Crystal Growth by Substituted Titanocenes

Suchergebnisse filtern